The Centers for Medicare and Medicaid Services wants to tap private sector expertise to help implement Medicare-negotiated “maximum fair prices” at the pharmacy counter beginning in 2026 for the 10 Part D drugs selected for the first round of negotiation, according to a request for information issued by the agency on 18 October.
Key Takeaways
-
The request for information explores how a private sector entity could handle the logistics of applying negotiated prices at the pharmacy counter.
The RFI is intended to “research the availability and potential technical ability of healthcare-related organizations to provide … data exchange,...







